Literature DB >> 26300032

A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.

Mark S Gold1, Rajendra D Badgaiyan2, Kenneth Blum3.   

Abstract

This article focuses on the shared molecular and neurogenetics of food and drug addiction tied to the understanding of reward deficiency syndrome. Reward deficiency syndrome describes a hypodopaminergic trait/state that provides a rationale for commonality in approaches for treating long-term reduced dopamine function across the reward brain regions. The identification of the role of DNA polymorphic associations with reward circuitry has resulted in new understanding of all addictive behaviors.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine agonistic therapy; Drug addiction; Food addiction; Genetic basis; Hypodopaminergic state; Molecular basis; Psychiatry

Mesh:

Substances:

Year:  2015        PMID: 26300032     DOI: 10.1016/j.psc.2015.05.011

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  14 in total

1.  Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial.

Authors:  K Blum; M Febo; R D Badgaiyan
Journal:  Austin Addict Sci       Date:  2016-10-12

2.  Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).

Authors:  Kenneth Blum; Marcelo Febo; Lyle Fried; Mona Li; Kristina Dushaj; Eric R Braverman; Thomas McLaughlin; Bruce Steinberg; Rajendra D Badgaiyan
Journal:  Subst Use Misuse       Date:  2016-12-29       Impact factor: 2.164

3.  Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

Authors:  Kenneth Blum; Edward J Modestino; Rajendra D Badgaiyan; David Baron; Panayotis K Thanos; Igor Elman; David Siwicki; Marcelo Febo; Mark S Gold
Journal:  EC Psychol Psychiatr       Date:  2018-07-30

4.  Neural and neurocognitive markers of vulnerability to gambling disorder: a study of unaffected siblings.

Authors:  Eve H Limbrick-Oldfield; Inge Mick; Rachel E Cocks; Remy S A Flechais; Samuel Turton; Anne Lingford-Hughes; Henrietta Bowden-Jones; Luke Clark
Journal:  Neuropsychopharmacology       Date:  2019-10-09       Impact factor: 7.853

Review 5.  Neuroimaging of reward mechanisms in Gambling disorder: an integrative review.

Authors:  Luke Clark; Isabelle Boileau; Martin Zack
Journal:  Mol Psychiatry       Date:  2018-09-13       Impact factor: 15.992

Review 6.  Converging vulnerability factors for compulsive food and drug use.

Authors:  Katherine M Serafine; Laura E O'Dell; Eric P Zorrilla
Journal:  Neuropharmacology       Date:  2021-04-20       Impact factor: 5.273

7.  Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?

Authors:  Kenneth Blum; Ali Raza; Tiffany Schultz; Rehan Jalali; Richard Green; Raymond Brewer; Panyotis K Thanos; Thomas McLaughlin; David Baron; Abdalla Bowirrat; Igor Elman; B William Downs; Debasis Bagchi; Rajendra D Badgaiyan
Journal:  Acta Sci Neurol       Date:  2021-02-02

8.  In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.

Authors:  Kenneth Blum; David Baron; Lisa Lott; Jessica V Ponce; David Siwicki; Brent Boyett; Bruce Steinberg; Edward J Modestino; Lyle Fried; Mary Hauser; Thomas Simpatico; Bill W Downs; Thomas McLaughlin; Raju Hajela; Rajendra D Badgaiyan
Journal:  Curr Psychopharmacol       Date:  2020

9.  Hypothesizing Balancing Endorphinergic and Glutaminergic Systems to Treat and Prevent Relapse to Reward Deficiency Behaviors: Coupling D-Phenylalanine and N-Acetyl-L-Cysteine (NAC) as a Novel Therapeutic Modality.

Authors:  Kenneth Blum; Marcelo Febo; Claudia Fahlke; Trevor Archer; U Berggren; Zsolt Demetrovics; Kristina Dushaj; Rajendra D Badgaiyan
Journal:  Clin Med Rev Case Rep       Date:  2015-12-17

10.  Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake.

Authors:  Lucien L Duquette; Frank Mattiace; Kenneth Blum; Roger L Waite; Teresa Boland; Thomas McLaughlin; Kristina Dushaj; Marcelo Febo; Rajendra D Badgaiyan
Journal:  Clin Med Rev Case Rep       Date:  2016-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.